InvestorsHub Logo
Followers 139
Posts 5289
Boards Moderated 0
Alias Born 03/01/2013

Re: symphon1 post# 36822

Monday, 05/22/2017 9:20:49 AM

Monday, May 22, 2017 9:20:49 AM

Post# of 37328
Stool-Bacterial-Pathogens-Panel-under-evaluation-at-over-40-sites...ahead-of-anticipated-FDA-clearance --
THAT IS HUGE!

Press Release: Great Basin Scientific Reports First Quarter 2017 Results
2 hours 15 minutes ago - DJNF
Great Basin Scientific Reports First Quarter 2017 Results

Company continues to reduce operating expenses and cash burn

-- First quarter revenue increased 14% year-over-year

-- 30% reduction in first quarter total operating expenses compared to

fourth quarter


-- First quarter net income was $21.5 million; non-GAAP net loss improved

27% from the fourth quarter

-- Stool Bacterial Pathogens Panel under evaluation at over 40 customer

sites ahead of anticipated FDA clearance

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.